If Ledipasvir/ Sofosbuvir Tablets is effective and affordable Then Why Are So Many People Still Dying from It?

Hepatitis C is a serious disease that ultimately leads to the death of the patients. The hepatitis C virus (HCV) has never seemed so close, yet the road ahead is precarious for the 5 million chronically infected people in Russia and about 30-40% people die each year from hepatitis.

However, humanity had a break-through that would radically change the lives of people living with Hepatitis C. Sofosbuvir and Ledipasvir, was approved for the treatment of Hepatitis C.

Combination of Ledipasvir and Sofosbuvir - double hit on HCV

The combination of Ledipasvir and Sofosbuvir is used alone or in combination with ribavirin to treat certain types of chronic hepatitis C (an ongoing viral infection that damages the liver) in adults. The combination Ledipasvir-Sofosbuvir taken orally is usually well-tolerated. Thus, the fixed-dose single-tablet combination of 90 mg of Ledipasvir and 400mg of Sofosbuvir offers a new era for the effective treatment of patients suffering from chronic infection with the hepatitis C virus.

Unfortunately, the price of original brand of Ledipasvir and Sofosbuvir is main barrier to access for a vast majority of people with HCV in Russia which is resulting in an increase in the number of deaths. In such condition, generics are the only hope for those people, because the cost of these drugs is about 97% lower than the cost of original medicines in India.

Generic Sofosbuvir and Ledipasvir are on the market which gives hope to more than 100,000 people infected with hepatitis C virus (HCV) in Russia. Indian Pharmaceutical Company - Natco Pharma, manufacture generic Ledipasvir-Sofosbuvir Tablets under the brand name Hepcinat LP . The Medicines Hepcinat-LP contains the standard dosage:

• Sofosbuvir - 400 mg;
• Ledipasvir - 90 mg.
• Number of tablets in one package - 28 pcs.

For more information About Hepcinat LP Tablets
Please Visit.

0 Comments Write your comment

    1. Loading...